The federal judges who heard arguments Wednesday in the fight over access to the most commonly used abortion pill in the U.S. were largely critical of the Biden administration’s position that the drug mifepristone should remain widely available. The three-judge panel in Louisiana grilled attorneys for the government and the drugmaker after the Supreme Court said last month that the status quo on mifepristone’s availability should remain in place while the appeals process plays out. |